tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

SERA Stock Latest News

Sera Prognostics Highlights PreTRM® at Healthcare Conference
Company AnnouncementsSera Prognostics Highlights PreTRM® at Healthcare Conference
6d ago
8K
SERA
Sera Prognostics Advances Maternal Health Research Initiatives
PremiumCompany Announcements
Sera Prognostics Advances Maternal Health Research Initiatives
12d ago
8K
SERA
Sera Prognostics Faces Business Continuity Risks Amid Data Dependency
PremiumCompany Announcements
Sera Prognostics Faces Business Continuity Risks Amid Data Dependency
2M ago
SERA
Sera Prognostics Reports Strategic Moves Amid Revenue Decline
PremiumCompany Announcements
Sera Prognostics Reports Strategic Moves Amid Revenue Decline
2M ago
SERA
Sera Prognostics files $100M mixed securities shelf
PremiumThe Fly
Sera Prognostics files $100M mixed securities shelf
5M ago
SERA
Sera Prognostics Inc trading resumes
PremiumThe FlySera Prognostics Inc trading resumes
6M ago
SERA
Sera Prognostics Inc trading halted, volatility trading pause
Premium
The Fly
Sera Prognostics Inc trading halted, volatility trading pause
6M ago
SERA
Sera Prognostics’ PreTRM test reduces neonatal morbidity, mortality by 18%
Premium
The Fly
Sera Prognostics’ PreTRM test reduces neonatal morbidity, mortality by 18%
6M ago
SERA
Sera Prognostics added to Russell 2000, Russell 3000 Indexes
PremiumThe Fly
Sera Prognostics added to Russell 2000, Russell 3000 Indexes
7M ago
SERA
Sera Prognostics set to be added to Russell 2000, 3000 indexes
PremiumThe Fly
Sera Prognostics set to be added to Russell 2000, 3000 indexes
8M ago
SERA
Four new option listings and one option delisting on April 24th
PremiumThe Fly
Four new option listings and one option delisting on April 24th
9M ago
EXPR
FSBC
Sera Prognostics’ PreTRM Test Faces Regulatory Risks: The Financial Implications of Potential FDA Hurdles
PremiumCompany Announcements
Sera Prognostics’ PreTRM Test Faces Regulatory Risks: The Financial Implications of Potential FDA Hurdles
10M ago
SERA
Sera Prognostics Unveils New Investor Presentation Update
PremiumCompany AnnouncementsSera Prognostics Unveils New Investor Presentation Update
10M ago
8K
SERA
Sera Prognostics reports Q4 EPS (25c) vs. (31c) last year
Premium
The Fly
Sera Prognostics reports Q4 EPS (25c) vs. (31c) last year
10M ago
SERA
Is SERA a Buy, Before Earnings?
Premium
Pre-Earnings
Is SERA a Buy, Before Earnings?
10M ago
SERA
Sera Prognostics halts PRIME study enrollment due to reaching efficacy endpoint
PremiumThe Fly
Sera Prognostics halts PRIME study enrollment due to reaching efficacy endpoint
1y ago
SERA
Sera Prognostics reports Q3 EPS (23c), consensus (34c)
PremiumThe Fly
Sera Prognostics reports Q3 EPS (23c), consensus (34c)
1y ago
SERA
Sera Prognostics reports Q2 EPS (34c), consensus (36c)
PremiumThe Fly
Sera Prognostics reports Q2 EPS (34c), consensus (36c)
1y ago
SERA
Sera Prognostics reports Q4 EPS (31c), consensus (37c)
PremiumThe Fly
Sera Prognostics reports Q4 EPS (31c), consensus (37c)
2y ago
SERA
Sera Prognostics Vaults Higher Thanks to New Test Data
PremiumMarket NewsSera Prognostics Vaults Higher Thanks to New Test Data
2y ago
SERA
Sera Prognostics’ PreTRM test shows predictive efficacy in Avert trial
Premium
The Fly
Sera Prognostics’ PreTRM test shows predictive efficacy in Avert trial
2y ago
SERA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >